Phibro Animal Health Corporation (NASDAQ:PAHC) Is Trading At A 26.86% Discount

Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of Phibro Animal Health Corporation (NASDAQ:PAHC) as an investment opportunity by projecting its future cash flows and then discounting them to today’s value. I will be using the discounted cash flows (DCF) model. It may sound complicated, but actually it is quite simple! If you want to learn more about discounted cash flow, the basis for my calcs can be read in detail in the Simply Wall St analysis model. If you are reading this and its not January 2019 then I highly recommend you check out the latest calculation for Phibro Animal Health by following the link below.

See our latest analysis for Phibro Animal Health

Want to help shape the future of investing tools and platforms? Take the survey and be part of one of the most advanced studies of stock market investors to date.

The model

I’m using the 2-stage growth model, which simply means we take in account two stages of company’s growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have perpetual stable growth rate. To start off with we need to estimate the next five years of cash flows. For this I used the consensus of the analysts covering the stock, as you can see below. I then discount this to its value today and sum up the total to get the present value of these cash flows.

5-year cash flow forecast

2019 2020 2021 2022 2023
Levered FCF ($, Millions) $86.00 $95.00 $112.00 $116.21 $120.58
Source Analyst x1 Analyst x1 Analyst x1 Est @ 3.76% Est @ 3.76%
Present Value Discounted @ 8.75% $79.08 $80.33 $87.08 $83.08 $79.27

Present Value of 5-year Cash Flow (PVCF)= US$409m

After calculating the present value of future cash flows in the intial 5-year period we need to calculate the Terminal Value, which accounts for all the future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of the GDP. In this case I have used the 10-year government bond rate (2.7%). In the same way as with the 5-year ‘growth’ period, we discount this to today’s value at a cost of equity of 8.8%.

Terminal Value (TV) = FCF2023 × (1 + g) ÷ (r – g) = US$121m × (1 + 2.7%) ÷ (8.8% – 2.7%) = US$2.1b

Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = US$2.1b ÷ ( 1 + 8.8%)5 = US$1.4b

The total value, or equity value, is then the sum of the present value of the cash flows, which in this case is US$1.8b. To get the intrinsic value per share, we divide this by the total number of shares outstanding, or the equivalent number if this is a depositary receipt or ADR. This results in an intrinsic value of $43.63. Compared to the current share price of $31.91, the stock is about right, perhaps slightly undervalued at a 27% discount to what it is available for right now.

NasdaqGM:PAHC Intrinsic Value Export January 17th 19
NasdaqGM:PAHC Intrinsic Value Export January 17th 19

The assumptions

I’d like to point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don’t have to agree with my inputs, I recommend redoing the calculations yourself and playing with them. Because we are looking at Phibro Animal Health as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighed average cost of capital, WACC) which accounts for debt. In this calculation I’ve used 8.8%, which is based on a levered beta of 0.828. This is derived from the Bottom-Up Beta method based on comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Whilst important, DCF calculation shouldn’t be the only metric you look at when researching a company. What is the reason for the share price to differ from the intrinsic value? For PAHC, I’ve put together three relevant factors you should further examine:

  1. Financial Health: Does PAHC have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
  2. Future Earnings: How does PAHC’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of PAHC? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow for every stock on the NASDAQ every 6 hours. If you want to find the calculation for other stocks just search here.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.